Natalie Staplin

PhD

MRC PHRU Senior Statistician

Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.

Recent publications

Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article

Horby PW. et al, (2020)
Development and internal validation of a risk score to detect asymptomatic carotid stenosis
Journal article

Poorthuis M. et al, (2020), European Journal of Vascular and Endovascular Surgery
Conventional and Genetic Evidence on the Association between Adiposity and CKD.
Journal article

Zhu P. et al, (2020), J Am Soc Nephrol
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Journal article

RECOVERY Collaborative Group None. et al, (2020), N Engl J Med
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article

RECOVERY Collaborative Group None., (2020), Lancet

More publications